Kathleen Weisel

547 total citations · 1 hit paper
13 papers, 424 citations indexed

About

Kathleen Weisel is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Kathleen Weisel has authored 13 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Kathleen Weisel's work include Immunodeficiency and Autoimmune Disorders (4 papers), Inflammatory Bowel Disease (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Kathleen Weisel is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (4 papers), Inflammatory Bowel Disease (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Kathleen Weisel collaborates with scholars based in United States, Canada and Italy. Kathleen Weisel's co-authors include Debra Tompson, Paul P. Tak, John Bertin, Monica Simeoni, Scott B. Berger, Nicola Scott, Silvio Danese, David T. Rubin, Julián Panés and Anita Afzali and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Kathleen Weisel

13 papers receiving 412 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

2022 132 citations William J. Sandborn, Geert D’Haens et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen Weisel United States	6	200	196	143	119	54	13	424
Alessandro Testori Italy	9	198 1.0×	58 0.3×	134 0.9×	50 0.4×	58 1.1×	13	379
Jun Matsuzawa Japan	7	159 0.8×	101 0.5×	98 0.7×	66 0.6×	95 1.8×	11	378
Subrata Banerjee India	13	269 1.3×	121 0.6×	72 0.5×	79 0.7×	159 2.9×	31	538
Yosuke Shimodaira Japan	10	102 0.5×	75 0.4×	108 0.8×	98 0.8×	41 0.8×	39	368
Thomas A. Zanardi United States	10	286 1.4×	115 0.6×	43 0.3×	42 0.4×	32 0.6×	13	492
Juo-Chin Yao United States	10	343 1.7×	112 0.6×	31 0.2×	66 0.6×	55 1.0×	17	500
Lone Frier Bovin Denmark	9	171 0.9×	117 0.6×	65 0.5×	35 0.3×	126 2.3×	11	376
Daniel Torres‐Moreno Spain	12	114 0.6×	97 0.5×	85 0.6×	49 0.4×	112 2.1×	24	399
Wai‐Hang Leung United States	11	134 0.7×	241 1.2×	46 0.3×	26 0.2×	105 1.9×	14	411
Souhir Mestiri Tunisia	9	163 0.8×	131 0.7×	70 0.5×	30 0.3×	124 2.3×	17	390

Countries citing papers authored by Kathleen Weisel

Since Specialization

Citations

This map shows the geographic impact of Kathleen Weisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Weisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Weisel more than expected).

Fields of papers citing papers by Kathleen Weisel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Weisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Weisel. The network helps show where Kathleen Weisel may publish in the future.

Co-authorship network of co-authors of Kathleen Weisel

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Weisel. A scholar is included among the top collaborators of Kathleen Weisel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Weisel. Kathleen Weisel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Cossu, Maria Laura, Amanda Jackson, Grace Liu, et al.. (2025). A randomized, open-label study on the effect of nipocalimab on vaccine responses in healthy participants. Human Vaccines & Immunotherapeutics. 21(1). 2491269–2491269. 3 indexed citations

Danese, Silvio, Remo Panaccione, David T. Rubin, et al.. (2022). OP24 Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn’s Disease: Week 48 analyses from the phase 2 GALAXI 1 study. Journal of Crohn s and Colitis. 16(Supplement_1). i026–i027. 18 indexed citations

Sandborn, William J., Geert D’Haens, Walter Reinisch, et al.. (2022). Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology. 162(6). 1650–1664.e8. 132 indexed citations breakdown →

Afzali, Anita, William J. Sandborn, Tadakazu Hisamatsu, et al.. (2021). S748 Early PRO-2 Symptom Remission Following Guselkumab Induction Treatment: Results Through Week 12 of the Phase 2 GALAXI 1 Study. The American Journal of Gastroenterology. 116(1). S344–S345. 1 indexed citations

Weisel, Kathleen, Scott B. Berger, Peter C. Taylor, et al.. (2021). A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis. Arthritis Research & Therapy. 23(1). 85–85. 63 indexed citations

Rubin, David T., Remo Panaccione, Geert D’Haens, et al.. (2021). S857 Patient-Reported Outcomes of Response and Remission Following Guselkumab Induction Treatment as Measured by the Inflammatory Bowel Disease Questionnaire: Results Through Week 12 of the Phase 2 GALAXI 1 Study. The American Journal of Gastroenterology. 116(1). S400–S400. 1 indexed citations

Danese, Silvio, W. Sandborn, Brian G. Feagan, et al.. (2021). OP28 The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn’s Disease: Results from the phase 2 GALAXI 1 study. Journal of Crohn s and Colitis. 15(Supplement_1). S027–S028. 2 indexed citations

Sands, Bruce E., Silvio Danese, Jane M. Andrews, et al.. (2021). Fr532 THE EFFECT OF GUSELKUMAB INDUCTION THERAPY ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 12 RESULTS FROM THE PHASE 2 GALAXI 1 STUDY. Gastroenterology. 160(6). S–350. 4 indexed citations

Weisel, Kathleen, Scott B. Berger, Kim Papp, et al.. (2020). Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled Study. Clinical Pharmacology & Therapeutics. 108(4). 808–816. 59 indexed citations

10.

Weisel, Kathleen, Nicola Scott, Debra Tompson, et al.. (2017). Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers. Pharmacology Research & Perspectives. 5(6). 106 indexed citations

11.

Gillmore, Julian D., et al.. (2016). HIGH CUT-OFF HAEMODIALYSIS (HCO-HD) DOES NOT IMPROVE OUTCOMES IN MYELOMA CAST NEPHROPATHY: RESULTS OF EUROPEAN TRIAL OF FREE LIGHT CHAIN REMOVAL BY EXTENDED HAEMODIALYSIS IN CAST NEPHROPATHY (EULITE). 5 indexed citations

12.

Weisel, Kathleen, Dan T. Vogl, Alessandro Corso, et al.. (2015). Health Resource Utilization with Continuous Lenalidomide Treatment (TX) in Elderly Patients (PTS) with newly diagnosed multiple myeloma (NDMM). Clinical Lymphoma Myeloma & Leukemia. 15. e166–e166. 1 indexed citations

13.

Japp, Alan G., Raj Chelliah, Ninian N. Lang, et al.. (2013). Effect of PSI‐697, a Novel P‐Selectin Inhibitor, on Platelet–Monocyte Aggregate Formation in Humans. Journal of the American Heart Association. 2(1). e006007–e006007. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact